Business Standard

Sunday, December 22, 2024 | 10:39 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Accord Group enters pharma business, targets sales in 18 states

The company has invested around Rs 600 crore into a manufacturing facility in Chennai and plans to invest around Rs 1,500 crore by March 2022, for R&D, acquisitions and others as part of expansion

pharma, medicines, drugs
Premium

Gireesh Babu Chennai
Chennai-based Accord Group, which is into diversified interests in medical education, a technical university, hospitals, breweries and hotels, has announced entry into domestic pharma market through Accord Life Spec, a pharmaceutical company it had initiated three years back. The company has invested around Rs 600 crore into a manufacturing facility in Chennai and plans to invest around Rs 1,500 crore by March 2022, for R&D, acquisitions and others as part of expansion.

Accord Group, founded by Dravida Munnetra Kazhagam (DMK) leader and former Union Minister S Jagathrakshakan, has recently bid for the debt-ridden Orchid Pharma under the Corporate Insolvency Resolution

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in